Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.84522 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.38367 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.13252 | 68 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.8179 | 64 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.01858 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.87061 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.1017 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.99926 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.37538 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.08358 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.02633 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.24048 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.08117 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.08098 | 67 |